Leading the Global Fight Against HIV/AIDS with Advanced ARV Solutions

In the rapidly evolving landscape of global healthcare, access to high-quality antiretroviral (ARV) medicines remains a critical pillar in controlling and managing HIV infections. As a specialized division of Taj Pharma India Ltd, Taj Medico stands at the forefront of this mission, delivering innovative, affordable, and globally compliant ARV formulations to healthcare systems worldwide.

We are committed to bridging treatment gaps by offering pharmaceutical excellence, regulatory compliance, and scalable manufacturing, ensuring that life-saving therapies reach every corner of the world. Our ARV portfolio is strategically developed to meet the needs of government tenders, NGOs, institutional buyers, and private distributors, making us a trusted partner in international markets.

Comprehensive ARV Product Portfolio – Taj Pharma Standard Format

We offer a diversified and clinically relevant ARV product range designed to support multiple treatment regimens, including first-line, second-line, and maintenance therapies.

Product NameBrand NameTherapeutic CategoryDosage FormAvailable StrengthsBCS Class (Estimate)
Elvitegravir + Cobicistat + Emtricitabine + Tenofovir Alafenamide TabletsELVITAJAntiretroviral (HIV)Tablet150 mg + 150 mg + 200 mg + 10 mgClass II / III
Elvitegravir + Cobicistat + Emtricitabine + Tenofovir Disoproxil FumarateELVITAJ-DFAntiretroviral (HIV)Tablet150 mg + 150 mg + 200 mg + 300 mgClass II / IV
Efavirenz + Emtricitabine + Tenofovir Disoproxil Fumarate TabletsEFTAJAntiretroviral (HIV)Tablet400 mg + 200 mg + 300 mgClass II / IV
Emtricitabine + Rilpivirine + Tenofovir Disoproxil Fumarate TabletsEMRITAJAntiretroviral (HIV)Tablet200 mg + 25 mg + 300 mgClass II / IV
Emtricitabine + Tenofovir Alafenamide TabletsEMTATAJAntiretroviral (HIV)Tablet200 mg + 25 mgClass III
Emtricitabine + Tenofovir Disoproxil Fumarate TabletsEMTDFTAJAntiretroviral (HIV)Tablet200 mg + 300 mgClass III / IV
Dolutegravir + Rilpivirine TabletsDOLRITAJAntiretroviral (HIV)Tablet50 mg + 25 mgClass II
Lopinavir + Ritonavir TabletsLOPRITAJAntiretroviral (HIV)Tablet500 mg + 150 mgClass IV
Lamivudine + Zidovudine TabletsLAMZITAJAntiretroviral (HIV)Tablet150 mg + 300 mgClass III
Abacavir TabletsABATAJAntiretroviral (HIV)Tablet300 mgClass III
Nevirapine TabletsNEVITAJAntiretroviral (HIV)Tablet200 mgClass II

Unwavering Commitment to Global HIV Treatment Standards

We strictly align our product development and manufacturing processes with the guidelines established by the World Health Organization. This ensures that every formulation we deliver adheres to international safety, efficacy, and quality benchmarks.

Our operational philosophy is built on:

  • WHO-GMP compliant manufacturing facilities
  • Robust quality assurance and validation systems
  • Cost-effective formulations for developing nations
  • Efficient and timely global supply chain management

These core principles position us as a preferred ARV supplier for global healthcare programs focused on HIV management and prevention.

Diverse Therapeutic Coverage Across ARV Drug Classes

Our portfolio is engineered to provide comprehensive therapeutic coverage across all major ARV drug classes:

Integrase Inhibitor-Based Combinations

We offer advanced formulations containing Elvitegravir and Dolutegravir, which are widely used in modern HIV treatment protocols due to their high efficacy and resistance barrier.

NRTI Backbone Therapies

Our products include essential nucleoside reverse transcriptase inhibitors such as:

  • Emtricitabine
  • Tenofovir (TDF & TAF)
  • Lamivudine

These serve as the foundation of combination antiretroviral therapy (cART).

NNRTI-Based Regimens

We manufacture reliable NNRTI-based combinations featuring:

  • Efavirenz
  • Nevirapine
  • Rilpivirine

These are critical in cost-effective treatment strategies, especially in resource-limited settings.

Protease Inhibitor Combinations

Our Lopinavir + Ritonavir formulation supports second-line treatment regimens, ensuring continued viral suppression in resistant cases.


Optimized Formulations for Patient Adherence

We prioritize fixed-dose combinations (FDCs) to simplify treatment regimens and improve patient compliance. These formulations reduce pill burden, enhance convenience, and support long-term viral suppression, which is essential for effective HIV management.


Advanced Manufacturing Excellence in India

Our manufacturing backbone is built on state-of-the-art pharmaceutical infrastructure, ensuring unmatched consistency and scalability. We deliver:

  • WHO-GMP certified production facilities
  • High-capacity manufacturing lines
  • Stringent in-process and finished product testing
  • Comprehensive documentation (CTD dossiers, COA, stability data)

Every batch is manufactured under strict regulatory supervision, ensuring global acceptance across multiple markets.


Strong Global Export Network

We have developed a robust international distribution network, enabling seamless supply of ARV medicines to:

  • Africa
  • Southeast Asia
  • Latin America
  • CIS countries

Our export capabilities include:

  • Government and institutional tender participation
  • NGO supply chain integration
  • Private labeling and contract manufacturing services
  • Custom packaging and regulatory support

This global reach allows us to deliver timely and reliable ARV supplies to high-demand regions.


Why We Are a Preferred ARV Supplier Globally

Our competitive advantage lies in delivering value-driven pharmaceutical solutions without compromising quality. We stand out due to:

  • End-to-end quality assurance systems
  • Cost-efficient bulk manufacturing
  • Deep regulatory expertise
  • Wide therapeutic coverage
  • Consistent product availability

We focus on long-term partnerships, ensuring that our clients benefit from reliable supply chains and consistent product performance.


Driving the Future of HIV Treatment

As global demand for ARV medicines continues to grow, we remain committed to expanding our portfolio, improving formulations, and enhancing accessibility. Our goal is to support universal access to HIV treatment, contributing to global health initiatives aimed at controlling and eventually eliminating HIV transmission.


Your Trusted Partner in ARV Supply

As a dedicated division of Taj Pharma India Ltd, we continue to strengthen our presence in the global ARV market through innovation, compliance, and customer-centric solutions. Our comprehensive ARV portfolio, combined with strong manufacturing and export capabilities, positions us as a reliable and strategic partner for healthcare organizations worldwide.

We remain committed to delivering high-quality, affordable, and effective antiretroviral medicines, ensuring better health outcomes and improved quality of life for patients globally.